Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records
JAMIA, 04/24/2012O'Reilly D et al.
The web–based prototype decision support system slightly improved short–term risk factors. The model predicted moderate improvements in long–term health outcomes. This disease management program will need to develop considerable efficiencies in terms of costs and processes or improved effectiveness to be considered a cost–effective intervention for treating patients with type 2 diabetes.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.